Table 4 Baseline characteristics of the TCGS cohort (1999–2017) participants used for the present study.
Variables | Prevalent T2D cases | Incident T2D cases | Non-progress cases to T2D |
|---|---|---|---|
Sex (Male/Female, number) | 295/424 | 515/633 | 1,163/1692 |
Age (mean ± SD) | 53 ± 11 | 45.5 ± 12 | 35 ± 12 |
Body mass index (mean ± SD) | 29 ± 4.5 | 28.97 ± 4.8 | 25 ± 4.3 |
Fasting plasma glucose (mean ± SD) | 163.57 ± 60 | 96.95 ± 11.13 | 84.7 ± 6.5 |
2-h plasma glucose (mean ± SD) | 269.8 ± 89.23 | 127.38 ± 32.8 | 91.9 ± 19.5 |
Cholesterol (mean ± SD) | 227.5 ± 48 | 219.23 ± 44 | 189 ± 41 |
High density lipoprotein cholesterol (mean ± SD) | 40.52 ± 10 | 40 ± 9.5 | 42.56 ± 10.5 |
Low density lipoprotein cholesterol (mean ± SD) | 141.5 ± 38 | 137.4 ± 34.5 | 119 ± 33.5 |
Triglyceride (mean ± SD) | 226 ± 111.5 | 180 ± 75 | 125 ± 65 |
Follow-up year (median, IQR) | 14 (10–17) | ||
